Renal and thymic pathology in thymona-associated nephropathy: Report of 21 cases and review of the literature

Nephrology Dialysis Transplantation

Volumn 20, Issue , 2005, Pages 1075-1082

  Karras, Alexandre ^a,c   de Montpreville, Vincent ^b   Fakhouri, Fadi ^a   Grünfeld, Jean Pierre ^a   Lesavre, Philippe ^a   Dracon, M ^d   Lelievre G ^d   Nivet, H ^d   Lebranchu, Y ^d   Baron, M ^d   Picaud, D ^d   Yver, L ^d   Rostoker, G ^d   Ryckelynck, J Ph ^d   Lobbedez, T ^d   Sadreux, Th ^d   Chauveau, D ^d   Pruna, A ^d   Bedrossian, J ^d   Cahen, R ^d   Trolliet, P ^d   Remy, Ph ^d   Deteix, P ^d   Choukroun, G ^d   Beaufils, H ^d   more..

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

^c FOCH HOSPITAL   (France)

^d NONE

Author keywords

Glomerulonephritis; Minimal change disease; Myasthenia gravis; Thymoma

Indexed keywords

ANTINEOPLASTIC AGENT; ANTINUCLEAR ANTIBODY; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; STEROID;

ACUTE KIDNEY FAILURE; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE RESISTANCE; DRUG EFFICACY; DRUG RESPONSE; FEMALE; FOCAL GLOMERULOSCLEROSIS; HEMODIALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOGAMMAGLOBULINEMIA; INFORMATION PROCESSING; KIDNEY BIOPSY; KIDNEY DISEASE; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MINIMAL CHANGE GLOMERULONEPHRITIS; MYASTHENIA GRAVIS; NEPHROTIC SYNDROME; PATHOPHYSIOLOGY; PEMPHIGUS; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RETROSPECTIVE STUDY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOTIC THROMBOCYTOPENIC PURPURA; THYMECTOMY; THYMOMA; THYMUS HYPERPLASIA;

ADULT; AGED; COMORBIDITY; FEMALE; HUMANS; HYPERPLASIA; KIDNEY; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; PROGNOSIS; RETROSPECTIVE STUDIES; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS;

EID: 20844447725     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/gfh615     Document Type: Article

References (24)

1. Thomas C, Wright C, Loehrer P. Thymoma, state of the art. J Clin Oncol 1999; 17: 2280-2289
2. Posner MR, Prout MN, Berk S. Thymoma and the nephrotic syndrome, a report of a case. Cancer 1980; 45: 387-391
3. Varsano S, Bruderman I, Bernheim J et al. Minimal-change nephropathy and malignant thymoma. Chest 1980; 77: 695-697
4. Calabrese L, Bach JF, Currie T et al. Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Arch Intern Med 1981; 141: 253-254
5. Scadding G, Sweny P, Wilson SG et al. Glomerulonephritis, thymoma and myasthenia gravis. Q J Med 1983; 76: 187-193
6. Le Loët X, Pouyol F, Lees O et al. Lupus érythémateux aigu disséminé survenu après thymectomie pour myasthénie. Rev Med Interne 1986; 7: 425-432
7. Ogawa M, Ueda S, Ohto M et al. Development of systemic lupus erythematosus after total resection of a thymoma and the adjacent thymic gland. J Rheum 1992; 19: 1130-1132
8. Ogawa M, Ueda S, Ohto M et al. Minimal change nephrotic syndrome developed after non-surgical treatment of a thymoma. Clin Nephrol 1992; 38: 171-172
9. McDonald P, Kalra PA, Coward RA. Thymoma and minimal-change glomerulonephritis. Nephrol Dial Transplant 1992; 7: 357-359
10. Jayasena S, Woolfson R, Griffiths M, Neild G. Nephrotic syndrome, malignant thymoma and myasthenia gravis. Am J Nephrol 1995: 15: 361-363
11. Ishida I, Hirakata H, Kanai H et al. Steroid-resistant nephrotic syndrome associated with malignant thymoma. Clin Nephrol 1996; 46: 340-346
12. Schillinger F, Milcent T, Wolf C et al. Nephrotic syndrome as the presenting feature of malignant thymoma. Nephrol Dial Transplant 1997; 12: 2732-2734
13. Zinger C, Ben-Itzhak O, Szylman P et al. Minimal-change nephropathy and malignant thymoma. Am J Nephrol 1998, 18: 61-63
14. Valli G, Fogazzi GB, Cappellari A, Rivolta E. Glomerulonephritis associated with myasthenia gravis. Am J Kidney Dis 1998; 31: 350-355
15. Lasseur C, Combe C, Deminiere C et al. Thymoma associated with myasthenia gravis and minimal lesion nephrotic syndrome. Am J Kidney Dis 1999; 33: E4
16. Matsuda M, Miki J, Tabata K et al. Myasthenia gravis with membranous nephropathy, successfully treated with extended total thymectomy. Int Med 2000; 39: 490-494
17. Le Berre L, Godfrin Y, Günther E et al. Extrarenal effects on the pathogenesis and relapse of idiopathic nephrotic syndrome in Buffalo/Mna rats. J Clin Invest 2002; 109: 491-498
18. Rosai J, Sobin LH. Histological Typing of Tumors of the Thymus. International Classification of Tumors, 2nd edn. Springer, New York, 1999
19. Masaoka A, Monden Y, Nakahara K, Tanioka T. Follow-up study of thymomas with special reference to their clinical stages. Cancer 1981; 48: 2485-2492
20. Hoffacker V, Schultz A, Tiesinga J et al. Thymomas alter the T-cell subset composition in the blood: a potential mechanism for thymoma-associated auto-immune disease. Blood 2000; 96: 3872-3879
21. Gerli R, Paganelli R, Cossarizza A et al. Long term immunologic effects of thymectomy in patients with myasthenia gravis. J Allergy Clin Immunol 1999; 103: 865-872
22. Mevorach D, Perrot S, Buchanan N et al. Appearance of SLE after thymectomy: four cases reports and review of the literature. Lupus 1995; 4: 33-37
23. Koyama A, Fujisaki M, Kobayashi M et al. A glomerular permeability factor produced by human T-cell hybridomas. Kidney Int 1991; 40: 453-460
24. Stephan JL, Deschenes G, Pérel Y et al. Nephrotic syndrome and Hodgkin disease in children: a report of five cases. Eur J Pediatr 1997; 156: 239-242